153 related articles for article (PubMed ID: 8980999)
41. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
Clark OH; Gerend PL
Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
[TBL] [Abstract][Full Text] [Related]
42. Toxic thyroid adenoma: absence of DNA mutations of the TSH receptor and Gs alpha.
Pinducciu C; Borgonovo G; Arezzo A; Torre GC; Giordano G; Cordera R
Eur J Endocrinol; 1998 Jan; 138(1):37-40. PubMed ID: 9461313
[TBL] [Abstract][Full Text] [Related]
43. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms.
Matsuo K; Friedman E; Gejman PV; Fagin JA
J Clin Endocrinol Metab; 1993 Jun; 76(6):1446-51. PubMed ID: 8501149
[TBL] [Abstract][Full Text] [Related]
44. Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis.
van Staveren WC; Solís DW; Delys L; Venet D; Cappello M; Andry G; Dumont JE; Libert F; Detours V; Maenhaut C
Proc Natl Acad Sci U S A; 2006 Jan; 103(2):413-8. PubMed ID: 16381821
[TBL] [Abstract][Full Text] [Related]
45. The thyrotropin receptor in thyroid diseases.
Paschke R; Ludgate M
N Engl J Med; 1997 Dec; 337(23):1675-81. PubMed ID: 9385128
[No Abstract] [Full Text] [Related]
46. [TSH receptors in autonomous thyroid adenoma].
Mueller-Gaertner HW
Acta Med Austriaca; 1990; 17 Suppl 1():12-5. PubMed ID: 2202176
[No Abstract] [Full Text] [Related]
47. Genetic alterations in thyroid hyperfunctioning adenomas.
Russo D; Arturi F; Wicker R; Chazenbalk GD; Schlumberger M; DuVillard JA; Caillou B; Monier R; Rapoport B; Filetti S
J Clin Endocrinol Metab; 1995 Apr; 80(4):1347-51. PubMed ID: 7714109
[TBL] [Abstract][Full Text] [Related]
48. [TSH receptors and signal transduction].
Kawakami Y; Fujita R; Okuda Y; Yamashita K
Nihon Rinsho; 1993 Oct; 51(10):2649-54. PubMed ID: 8254934
[TBL] [Abstract][Full Text] [Related]
49. [TSH receptor double mutation in functional autonomic thyroid nodule].
Semlitsch G; Höfler G; Langsteger W; Lax S; Zatloukal K; Berger A; Eber O
Acta Med Austriaca; 1995; 22(4):75-7. PubMed ID: 8835426
[TBL] [Abstract][Full Text] [Related]
50. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
[TBL] [Abstract][Full Text] [Related]
51. Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology.
Deleu S; Allory Y; Radulescu A; Pirson I; Carrasco N; Corvilain B; Salmon I; Franc B; Dumont JE; Van Sande J; Maenhaut C
Thyroid; 2000 Feb; 10(2):131-40. PubMed ID: 10718549
[TBL] [Abstract][Full Text] [Related]
52. Mutations of thyrotropin receptor gene.
Porcellini A; Fenzi G; Avvedimento EV
J Mol Med (Berl); 1997 Aug; 75(8):567-75. PubMed ID: 9297624
[TBL] [Abstract][Full Text] [Related]
53. Gs alpha mutations in hyperfunctioning thyroid adenomas.
Murakami M; Kamiya Y; Yanagita Y; Mori M
Arch Med Res; 1999; 30(6):514-21. PubMed ID: 10714366
[TBL] [Abstract][Full Text] [Related]
54. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.
Kopp P; Muirhead S; Jourdain N; Gu WX; Jameson JL; Rodd C
J Clin Invest; 1997 Sep; 100(6):1634-9. PubMed ID: 9294132
[TBL] [Abstract][Full Text] [Related]
55. Gi alpha-1 expression in the human thyroid is regulated by TSH: loss of regulation in thyroid autonomous adenoma.
Selzer E; Schiferer A; Hermann M; Grubeck-Loebenstein B; Freissmuth M
Thyroidology; 1992 Apr; 4(1):7-10. PubMed ID: 1284336
[TBL] [Abstract][Full Text] [Related]
56. Autoradiographical evidence for increased thyrotropin binding to autonomously functioning thyroid gland tissue.
Müller-Gärtner HW; Jessel M; Schneider C; Bay V
J Endocrinol Invest; 1988 Mar; 11(3):183-91. PubMed ID: 3372958
[TBL] [Abstract][Full Text] [Related]
57. Autonomous adenomas caused by somatic mutations of the thyroid-stimulating hormone receptor in children.
Grob F; Deladoëy J; Legault L; Spigelblatt L; Fournier A; Vassart G; Van Vliet G
Horm Res Paediatr; 2014; 81(2):73-9. PubMed ID: 24480816
[TBL] [Abstract][Full Text] [Related]
58. [Activating mutations of the TSH receptor: a synthesis highlighting certain pediatric aspects].
Polak M
Arch Pediatr; 1998; 5 Suppl 4():375S-379S. PubMed ID: 9853087
[TBL] [Abstract][Full Text] [Related]
59. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
[TBL] [Abstract][Full Text] [Related]
60. Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas.
Kamiya Y; Murakami M; Yanagita Y; Koitabashi H; Nagamachi Y; Hosoi Y; Ogiwara T; Mizuma H; Iriuchijima T; Mori M
Mol Cell Endocrinol; 1998 Mar; 138(1-2):137-42. PubMed ID: 9685222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
